Announced new clinical trial agreement with Pfizer to evaluate palazestrant in combination withatirmociclib in ER+/HER2- metastatic breast cancerInitiated OPERA-02 Phase 3 trial of palazestrant in ...
Despite BigBear.ai's EBITDA losses widening and the company's revenue falling, its share price has soared over the past several years, rising 452%. That rapid increase means that BigBear.ai's price-to ...
It seems that with Trump's arrival at the White House, all those initiatives implemented during Biden's administration, especially those that favored the ...